Search Within

Sam Yoon

  1. "Sarcoma Service"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (16)
  2. Sarcoma Service (16)
  3. Solid Tumor Oncology Division (16)
  4. Department of Pathology and Laboratory Medicine (10)
  5. GSK Faculty (10)
  6. Human Oncology and Pathogenesis Program (10)

More Groups

People
  1. William Tap (16)
  2. Cristina Antonescu (10)
  3. Samuel Singer (10)
  4. Aimee Crago (9)
  5. Ciara Kelly (9)
  6. Mark Dickson (9)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (1)
  4. 2020 (2)
  5. 2019 (1)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Clinical Cancer Research (2)
  3. Annals of Surgery (1)
  4. British Journal of Cancer (1)
  5. Cancer Research (1)
  6. International Journal of Radiation Oncology, Biology, Physics (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. American Association for Cancer Research (3)
  3. Nature Publishing Group (3)
  4. American Medical Association (1)
  5. Elsevier Inc. (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The clinical impact of performing routine next generation sequencing (NGS) in gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Vonya, T.; Yoon, S. S.; Singer, S.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Platelet-derived growth factor receptor alpha promotes cancer stem-like cell phenotypes in sarcomas including metastasis and chemotherapy resistance
    Meeting Abstract

    Chang, K. K.; Yoon, C.; Tap, W. D.; Yoon, S. S.
    Journal of the American College of Surgeons (2016)

    Fulltext@MSK | Save
  • [RETRACTION] Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy
    Journal Article

    Yoon, C.; Chang, K. K.; Lee, J. H.; Tap, W. D.; Hart, C. P.; Simon, M. C.; Yoon, S. S.
    Oncotarget (2016)

    Fulltext@MSK | Save
  • Hypoxia-activated chemotherapeutic TH-302 enhances the effects of VEGF-A inhibition and radiation on sarcomas
    Journal Article

    Yoon, C.; Lee, H. J.; Park, D. J.; Lee, Y. J.; Tap, W. D.; Eisinger-Mathason, T. S. K.; Hart, C. P.; Choy, E.; Simon, M. C.; Yoon, S. S.
    British Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Inhibition of vascular endothelial growth factor a and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature
    Journal Article

    Lee, H. J.; Yoon, C.; Park, D. J.; Kim, Y. J.; Schmidt, B.; Lee, Y. J.; Tap, W. D.; Eisinger-Mathason, T. S. K.; Choy, E.; Kirsch, D. G.; more...
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Targeting vascular endothelial growth factor A and tumor hypoxia combined with radiation eradicates sarcomas through destruction of tumor vasculature and thwarting of the hypoxic response
    Meeting Abstract

    Yoon, C.; Lee, H. J.; Park, D. J.; Tap, W. D.; Eisinger-Mathason, T. S. K.; Kirsch, D. G.; Simon, M. C.; Yoon, S. S.
    Cancer Research (2014)

    Fulltext@MSK | Save